O
Ole Wichmann
Researcher at Robert Koch Institute
Publications - 228
Citations - 7533
Ole Wichmann is an academic researcher from Robert Koch Institute. The author has contributed to research in topics: Vaccination & Population. The author has an hindex of 43, co-authored 200 publications receiving 6223 citations. Previous affiliations of Ole Wichmann include Ludwig Maximilian University of Munich & Humboldt University of Berlin.
Papers
More filters
Journal ArticleDOI
Influenza and pertussis vaccination during pregnancy – attitudes, practices and barriers in gynaecological practices in Germany
Stefanie Böhm,Marianne Röbl-Mathieu,Burkhard Scheele,Michael Wojcinski,Ole Wichmann,Wiebke Hellenbrand +5 more
TL;DR: The large proportion reporting performance of influenza vaccination during pregnancy and high acceptance of a potential recommendation for pertussis vaccination reflected positive attitudes towards vaccination among participants, suggesting that gynaecologists’ confidence in vaccination is crucial for implementing vaccination in pregnancy.
Journal ArticleDOI
How baby’s first shot determines the development of maternal attitudes towards vaccination
TL;DR: Assessment of how and why attitudes become more pro-vaccine or vaccine-skeptical over time, and which sources are especially influential in this process, found that maternal attitudes towards vaccination are formed and guide future decisions whether to vaccinate or not vaccinate a child.
Journal ArticleDOI
HPV vaccination coverage among women aged 18-20 years in Germany three years after recommendation of HPV vaccination for adolescent girls: results from a cross-sectional survey.
TL;DR: There is an urgent need for the implementation of a coordinated adolescent vaccination program to facilitate access to vaccination, including balanced information tailored to this age group, because HPV-vaccination coverage is low in Germany.
National Advisory Groups and their role in immunization policy-making processes in European countries
TL;DR: In a survey performed among European Union member states, Norway and Iceland, in February 2013, 85% of the 27 responding countries reported having established a NITAG, and of these, 45% have formal frameworks in place for the systematic development of vaccination recommendations as mentioned in this paper.
Journal ArticleDOI
Current and future effects of varicella and herpes zoster vaccination in Germany – Insights from a mathematical model in a country with universal varicella vaccination
Johannes Horn,André Karch,Oliver Damm,Mirjam Kretzschmar,Anette Siedler,Bernhard Ultsch,Felix Weidemann,Ole Wichmann,Hartmut Hengel,Wolfgang Greiner,Rafael T. Mikolajczyk +10 more
TL;DR: The model's results provide valuable insights that support decision-making regarding national VZV vaccination strategies and are shown to decrease in the long-term by 58% as vaccinated individuals get older and finally reach age-classes with originally high HZ incidence.